These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30783518)

  • 1. Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells.
    Mungra N; Jordaan S; Hlongwane P; Naran K; Chetty S; Barth S
    Oncotarget; 2019 Jan; 10(8):897-915. PubMed ID: 30783518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.
    Jordaan S; Akinrinmade OA; Nachreiner T; Cremer C; Naran K; Chetty S; Barth S
    Biomedicines; 2018 Mar; 6(1):. PubMed ID: 29510557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Granzyme B Based Targeted Cytolytic Fusion Proteins.
    Hlongwane P; Mungra N; Madheswaran S; Akinrinmade OA; Chetty S; Barth S
    Biomedicines; 2018 Jun; 6(2):. PubMed ID: 29925790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells.
    Schiffer S; Letzian S; Jost E; Mladenov R; Hristodorov D; Huhn M; Fischer R; Barth S; Thepen T
    Cancer Lett; 2013 Dec; 341(2):178-85. PubMed ID: 23973499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation.
    Bochicchio A; Jordaan S; Losasso V; Chetty S; Perera RC; Ippoliti E; Barth S; Carloni P
    Biomedicines; 2017 Feb; 5(1):. PubMed ID: 28536352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies.
    Biteghe FAN; Mungra N; Chalomie NET; Ndong JC; Engohang-Ndong J; Vignaux G; Padayachee E; Naran K; Barth S
    Oncotarget; 2020 Sep; 11(38):3531-3557. PubMed ID: 33014289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human MAP Tau Based Targeted Cytolytic Fusion Proteins.
    Akinrinmade OA; Jordaan S; Hristodorov D; Mladenov R; Mungra N; Chetty S; Barth S
    Biomedicines; 2017 Jun; 5(3):. PubMed ID: 28653985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.
    Amoury M; Mladenov R; Nachreiner T; Pham AT; Hristodorov D; Di Fiore S; Helfrich W; Pardo A; Fey G; Schwenkert M; Thepen T; Kiessling F; Hussain AF; Fischer R; Kolberg K; Barth S
    Int J Cancer; 2016 Aug; 139(4):916-27. PubMed ID: 27037627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic strategies to selectively kill cancer cells.
    Panchal RG
    Biochem Pharmacol; 1998 Feb; 55(3):247-52. PubMed ID: 9484789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
    Niesen J; Hehmann-Titt G; Woitok M; Fendel R; Barth S; Fischer R; Stein C
    Cancer Lett; 2016 May; 374(2):229-40. PubMed ID: 26912070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations.
    Cong X; Cremer C; Nachreiner T; Barth S; Carloni P
    Protein Sci; 2016 Aug; 25(8):1451-60. PubMed ID: 27110669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.
    Jordaan S; Chetty S; Mungra N; Koopmans I; van Bommel PE; Helfrich W; Barth S
    Biomedicines; 2017 Jun; 5(3):. PubMed ID: 28657611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.
    Hristodorov D; Nordlohne J; Mladenov R; Huhn M; Fischer R; Thepen T; Barth S
    Br J Haematol; 2014 Jan; 164(2):251-7. PubMed ID: 24164493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of DAP Kinase Tumor Suppressor Function: A Therapeutic Strategy to Selectively Induce Apoptosis in Cancer Cells Using Immunokinase Fusion Proteins.
    Tur MK; Daramola AK; Gattenlöhner S; Herling M; Chetty S; Barth S
    Biomedicines; 2017 Oct; 5(4):. PubMed ID: 28976934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins.
    Schiffer S; Rosinke R; Jost E; Hehmann-Titt G; Huhn M; Melmer G; Barth S; Thepen T
    Int J Cancer; 2014 Sep; 135(6):1497-508. PubMed ID: 24523193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modularly Constructed Synthetic Granzyme B Molecule Enables Interrogation of Intracellular Proteases for Targeted Cytotoxicity.
    Ho P; Ede C; Chen YY
    ACS Synth Biol; 2017 Aug; 6(8):1484-1495. PubMed ID: 28510446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.